Guilin China Resources Tianhe Pharmaceutical Co., Ltd.

Form 483FOIA Uncovered

Guilin, -, ChinaFEI 3003704959Issued January 11, 2019

View FDA's Record for This Firm

Source: FDA inspection record. Confirmed against FDA's published inspection data for this establishment and inspection date. FDA has published the inspection and what it cited, but not the form itself, which usually takes six to twelve months. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 3003704959.

Observations2

Issue DateJanuary 11, 2019

StatusNo Warning Letter

Related Inspections2

Establishment Details

Firm: Guilin China Resources Tianhe Pharmaceutical Co., Ltd.
Location: Guilin, -, China
FEI Number: 3003704959
Product Type: Drugs
Issue Date: January 11, 2019
Country: China

Inspection History, 2019 to 2025

VAI2

VAI means Voluntary Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Guilin China Resources Tianhe Pharmaceutical Co., Ltd. FDA Form 483, Guilin, January 11, 2019